Privia Health Group Inc

Análisis de la acción Privia Health Group Inc (PRVA)

$22.620

+0.991 (+4.38%)Al cierre

Loading chart…
Máximo
22.730
Apertura
21.970
Precio medio ponderado por volumen
22.41
Volumen
2.00M
Capitalización
2.04B
Mínimo
21.885
Importe
44.87M
EV/EBITDA, TTM
-6,438.54

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

Análisis de IA of Privia Health Group Inc (PRVA)

Comprar

Privia Health Group Inc is a good buy right now due to its current price of $20.85, which is significantly below the analyst price target of $35, indicating a potential upside of 68%. Additionally, the company reported a solid 12.4% year-over-year increase in practice collections for Q2 2026, showcasing strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect short-term investor sentiment.

Métricas de valoración

El PER previsto actual de Privia Health Group Inc (PRVA) es 17.27, frente a su media de 5 años de 59.16.

PER previsto

Valor razonable
Media 5A P/E
59.16
P/E actual
17.27
Sobrevalorada
343.85
Infravalorada
-225.53

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
-109.44
EV/EBITDA actual
-6438.54
Sobrevalorada
992.97
Infravalorada
-1211.86

Precio/ventas previsto

Infravalorado
Media 5A P/S
1.61
P/S actual
1.03
Sobrevalorada
2.11
Infravalorada
1.11

Escenarios de precio de Alphio AI para PRVA

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%PRVA

$29.18

Precio del escenario

B

Base

Base · 50%PRVA

$27.83

Precio del escenario

B

Bajista

Bajista · 25%PRVA

$24.83

Precio del escenario

Ballenas con PRVA en cartera

R

Riverbridge Partners, LLC

+ Con en carteraPRVA

+4.83%

Rentabilidad a 3 meses

D

Durable Capital Partners, LP

+ Con en carteraPRVA

-3.58%

Rentabilidad a 3 meses

Cronología de eventos

2026-08-06 (ET)

06:30:00

Company Reports Q2 Revenue of $632.6M

06:30:00

FY26 Consensus at $2.42, Adjusted EBITDA Expected in $145M-$155M Range

2026-05-27 (ET)

09:10:00

Privia Health Signs Agreement with NGBC to Enter New Jersey

2026-05-07 (ET)

06:20:00

Company Reports Q1 Revenue of $603.8M, Exceeds Consensus

2026-02-26 (ET)

06:30:00

Company Reports Q4 Revenue of $541.2M

Noticias

Preguntas frecuentes sobre PRVA, respondidas por Alphio AI

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Privia Health Group Inc is a good buy right now due to its current price of $20.85, which is significantly below the analyst price target of $35, indicating a potential upside of 68%. Additionally, the company reported a solid 12.4% year-over-year increase in practice collections for Q2 2026, showcasing strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect short-term investor sentiment.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar